InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Sharp Shalini, Director. Director active across 4 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 12 disclosures have been logged. Activity tracked since 14 January 2022. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
18,980 sharesShareXHKGHKEX:DA20260616E00304
Ideal exit: 8 Mar 2027 (T+270)
18,980 sharesOrdinary SharesSEC:0001377202-26-000007:0
117 sharesShareXHKGHKEX:DA20260515E00446
Ideal exit: 24 Jun 2025 (T+270)
10,985 shares0Ordinary SharesSEC:0001651308-25-000090:0
1,435 shares0Common StockSEC:0000914475-25-000131:0
8,151 shares0Ordinary SharesSEC:0001651308-24-000131:0
2,100 shares0Common StockSEC:0000914475-24-000138:0
4,162 sharesCommon StockSEC:0001140361-24-003537:0
6,808 shares@ US$58.75100.0% of flowCommon StockSEC:0001628280-24-000302:0
4,444 shares0Common StockSEC:0001214659-23-001038:0
2,546 shares0Common StockSEC:0001214659-22-000841:0
2,546 shares0Common StockSEC:0001214659-22-000841
12 of 12 declarations
About Sharp Shalini
Shalini Sharp serves as a Board Member at Mirati Therapeutics, Inc. She brings her expertise in corporate governance and strategy to the board. Shalini plays a key role in strategic decision-making and the future direction of the company, thereby contributing to its success in the biopharmaceutical sector.
